Ziopharm Tests "Sleeping Beauty" for Oncology Treatment

Ziopharm Oncology (ZIOP) recently announced that the FDA has cleared an investigational new drug application (IND) for a Phase I trial to test their 3rd generation CD19-specific CAR-T, explains biotech sector specialist John McCamant, editor of The Medical Technology Stock Letter.